高风险妊娠中扩展性无创产前筛查与染色体微阵列分析临床效用的对比研究
这项多中心回顾性研究纳入774例染色体异常高风险单胎妊娠,比较扩展性NIPS与CMA的检测一致性。结果显示CMA对<5 Mb拷贝数变异检出率高于NIPS(7.9% vs 3.1%),且5.8% NIPS阴性或不可报告者经CMA检出基因异常,提示高风险妊娠应优先提供CMA。
要点
- 高风险妊娠中CMA对<5 Mb拷贝数变异检出率高于扩展性NIPS(7.9% vs 3.1%)。
- NIPS阴性或不可报告的高风险妊娠中,5.8%经CMA检出基因异常。
- 21、18、13三体NIPS与CMA完全或部分一致率分别为82.2%、59.6%、25.0%。
核心结论
- CMA可全面检测高风险妊娠的全基因组染色体异常,应替代扩展性NIPS提供给高风险妊娠。
研究设计与样本
- 多中心回顾性研究,纳入2015至2019年依次接受扩展性NIPS和CMA的774例染色体异常高风险单胎妊娠,排除性染色体非整倍体阳性者。
主要发现
- 774例中NIPS阳性550例(71.1%),CMA阳性308例(39.8%)。
- 21、18、13三体NIPS与CMA完全或部分一致率分别为82.2%、59.6%、25.0%。
- 罕见非整倍体和节段性失衡的NIPS与CMA完全或部分一致率分别为7.5%和33.3%。
- CMA检出<5 Mb拷贝数变异的发生率为7.9%(61/774),NIPS为3.1%(24/774)。
- NIPS阴性或不可报告的高风险妊娠中,CMA检出基因异常的比例为1/17(5.8%)。
临床怎么用
- 对染色体异常高风险妊娠,应优先提供CMA而非扩展性NIPS进行产前检测。
- NIPS阴性或不可报告的高风险妊娠仍需考虑CMA以检出可能遗漏的基因异常。
局限性
- 性染色体非整倍体阳性妊娠因无法获取完整资料而被排除。
- 为回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the utility of expanded non-invasive prenatal screening (NIPS), compared with chromosomal microarray analysis (CMA), for the detection of chromosomal abnormalities in high-risk pregnancies. METHODS: This was a multicenter retrospective study of singleton pregnancies at high risk for chromosomal abnormality. Patients who underwent expanded NIPS and CMA sequentially during pregnancy from 2015 to 2019 were included in the analysis. Pregnancies with a positive result for sex chromosome aneuploidy were excluded as the full details could not be retrieved. The utility of expanded NIPS and CMA for detection of chromosomal abnormalities in this cohort was compared by assessing the concordance between the results. RESULTS: Of the 774 included high-risk pregnancies, 550 (71.1%) had a positive NIPS result, while a positive CMA result was detected in 308 (39.8%) cases. The rate of full or partial concordance between NIPS and CMA was 82.2%, 59.6% and 25.0% for trisomies 21, 18 and 13, respectively. For rare aneuploidies and segmental imbalances, NIPS and CMA results were fully or partially concordant in 7.5% and 33.3% of cases, respectively. Copy-number variants < 5 Mb were detected more often by CMA, with an incidence of 7.9% (61/774) compared with 3.1% (24/774) by NIPS. A genetic aberration was detected by CMA in 1 in 17 (5.8%) high-risk pregnancies that had a negative or non-reportable NIPS result. CONCLUSION: CMA allows for comprehensive detection of genome-wide chromosomal abnormalities in high-risk pregnancies. CMA should be offered instead of expanded NIPS for high-risk pregnancies. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Zhu X, Chen M, Wang H, et al. Clinical utility of expanded non-invasive prenatal screening and chromosomal microarray analysis in high-risk pregnancy. Ultrasound Obstet Gynecol. 2021. PMID: 32198896. doi:10.1002/uog.22021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。